CCR4 and glioma: CCL2 recruits immunosuppressive regulatory T cells that express CCR4 to induce Tregs migration to glioma tissue for immune evasion, which is the main sign of tumorigenesis and a powerful obstacle to effective cancer treatment in gliomas [37].